The upper and lower respiratory tracts differ in their requirement of IFN-γ and IL-4 in controlling respiratory mycoplasma infection and disease

Journal of Immunology

Volumn 172, Issue 11, 2004, Pages 6875-6883

  Woolard, Matthew D ^a   Hodge, Lisa M ^a   Jones, Harlan P ^b   Schoeb, Trenton R ^c   Simecka, Jerry W ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; KNOCKOUT MOUSE; LOWER RESPIRATORY TRACT INFECTION; MACROPHAGE; MOUSE; MYCOPLASMA; NONHUMAN; NOSE; OLFACTORY SYSTEM; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; TH2 CELL; UPPER RESPIRATORY TRACT INFECTION;

EID: 2442640280     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.11.6875     Document Type: Article

References (61)

1. Cassell, G. H., and J. K. Davis. 1978. Protective effect of vaccination against Mycoplasma pulmonis respiratory disease in rats. Infect. Immun. 21:69.
2. Foy, H. M. 1993. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin. Infect. Dis. 17(Suppl. 1):S37.
3. Foy, H. M., G. E. Kenny, M. K. Cooney, and I. D. Allan. 1979. Long-term epidemiology of infections with Mycoplasma pneumoniae. J. Infect. Dis. 139:681.
4. Krause, D. C., and D. Taylor-Robinson. 1993. Mycoplasma which infect humans. In Mycoplasmas: Molecular Biology and Pathogenosis. J. Manilof, R. N. McElhaney, L. R. Finch, and J. B. Baseman, eds. American Society of Microbiology, Washington D.C., p. 417.
5. Freymuth, F., A. Vabret, J. Brouard, F. Toutain, R. Verdon, J. Petitjean, S. Gouarin, J. F. Duhamel, and B. Guillois. 1999. Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children. J. Clin. Virol. 13:131.
6. Martin, R. J., M. Kraft, H. W. Chu, E. A. Berns, and G. H. Cassell. 2001. A link between chronic asthma and chronic infection. J. Allergy Clin. Immunol. 107:595.
7. Dajani, A. S., W. A. J. Clyde, and F. W. Denny. 1965. Experimental infection with Mycoplasma pneumoniae (Eaton's agent). J. Exp. Med. 121:1071.
8. Cassel, G. H., J. R. Lindsey, R. G. Overcash, and H. J. Baker. 1973. Murine mycoplasma respiratory disease. Ann. NY Acad. Sci. 225:395.
9. Cartner, S. C., J. W. Simecka, J. R. Lindsey, G. H. Cassell, and J. K. Davis. 1995. Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response. Infect. Immun. 63:4138.
10. Yancey, A. L., H. L. Watson, S. C. Cartner, and J. W. Simecka. 2001. Gender is a major factor in determining the severity of mycoplasma respiratory disease in mice. Infect. Immun. 69:2865.
11. Evengard, B., K. Sandstedt, G. Bolske, R. Feinstein, I. Riesenfelt-Orn, and C. I. Smith. 1994. Intranasal inoculation of Mycoplasma pulmonis in mice with severe combined immunodeficiency (SCID) causes a wasting disease with grave arthritis. Clin. Exp. Immunol. 98:388.
12. Keystone, E. C., D. Taylor-Robinson, M. F. Osborn, L. Ling, C. Pope, and V. Fornasier. 1980. Effect of T-cell deficiency on the chronicity of arthritis induced in mice by Mycoplasma pulmonis. Infect. Immun. 27:192.
13. Mizutani, H., T. Kitayama, A. Hayakawa, and E. Nagayama. 1971. Delayed hypersensitivity in Mycoplasma pneumoniae infections. Lancet 1:186.
14. Taylor, G., D. Taylor-Robinson, and G. W. Fernald. 1974. Reduction in the severity of Mycoplasma pneumoniae-induced pneumonia in hamsters by immunosuppressive treatment with antithymocyte sera. J. Med. Microbiol. 7:343.
15. Cartner, S. C., J. R. Lindsey, J. Gibbs-Erwin, G. H. Cassell, and J. W. Simecka. 1998. Roles of innate and adaptive immunity in respiratory mycoplasmosis. Infect. Immun. 66:3485.
16. + Th cell-associated inflammatory lesions during murine mycoplasma respiratory disease. J. Immunol. 168:3493.
17. Jones, H. P., L. M. Hodge, K. Fujihashi, H. Kiyono, J. R. McGhee, and J. W. Simecka. 2001. The pulmonary environment promotes Th2 cell responses after nasal-pulmonary immunization with antigen alone, but Th1 responses are induced during instances of intense immune stimulation. J. Immunol. 167:4518.
18. Constant, S. L., K. S. Lee, and K. Bottomly. 2000. Site of antigen delivery can influence T cell priming: pulmonary environment promotes preferential Th2-type differentiation. Eur. J. Immunol. 30:840.
19. Simecka, J. W., P. Patel, J. K. Davis, S. E. Ross, P. Otwell, and G. H. Cassell. 1991. Specific and nonspecific antibody responses in different segments of the respiratory tract in rats infected with Mycoplasma pulmonis. Infect. Immun. 59:3715.
20. Hodge, L. M., M. Marinaro, H. P. Jones, J. R. McGhee, H. Kiyono, and J. W. Simecka. 2001. Immunoglobulin A (IgA) responses and IgE-associated inflammation along the respiratory tract after mucosal but not systemic immunization. Infect. Immun. 69:2328.
21. Liang, S. C., J. W. Simecka, J. R. Lindsey, G. H. Cassell, and J. K. Davis. 1999. Antibody responses after Sendai virus infection and their role in upper and lower respiratory tract disease in rats. Lab. Anim. Sci. 49:385.
22. Chan, S. H., B. Perussia, J. W. Gupta, M. Kobayashi, M. Pospisil, H. A. Young, S. F. Wolf, D. Young, S. C. Clark, and G. Trinchieri. 1991. Induction of interferon γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:869.
23. + natural killer T cells by Mycobacterium bovis bacillus Calmette Guerin. Eur. J. Immunol. 29:650.
24. + T cells produce IFN-γ and IL-5. J. Immunol. 147:3736.
25. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259:1739.
26. Reiner, S. L. 2001. Helper T cell differentiation, inside and out. Curr. Opin. Immunol. 13:351.
27. Haas, H., F. H. Falcone, M. J. Holland, G. Schramm, K. Haisch, B. F. Gibbs, A. Bufe, and M. Schlaak. 1999. Early interleukin-4: its role in the switch towards a Th2 response and IgE-mediated allergy. Int. Arch. Allergy Immunol. 119:86.
28. + Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses. Infect. Immun. 64:1516.
29. Noben-Trauth, N., G. Kohler, K. Burki, and B. Ledermann. 1996. Efficient targeting of the IL-4 gene in a BALB/c embryonic stem cell line. Transgenic Res. 5:487.
30. Davidson, M. K., J. K. Davis, J. R. Lindsey, and G. H. Cassell. 1988. Clearance of different strains of Mycoplasma pulmonis from the respiratory tract of C3H/ HeN mice. Infect. Immun. 56:2163.
31. Simecka, J. W., R. B. Thorp, and G. H. Cassell. 1992. Dendritic cells are present in the alveolar region of lungs from specific pathogen-free rats. Reg. Immunol. 4:18.
32. Van Ginkel, F. W., C. Liu, J. W. Simecka, J. Y. Dong, T. Greenway, R. A. Frizzell, H. Kiyono, J. R. McGhee, and D. W. Pascual. 1995. Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and β-galactosidase. Hum. Gene Ther. 6:895.
33. Kruisbeek, A. 1999. Isolation and fractionation of mononuclear cell population. In Current Protocols in Immunology, Vol. 1. A. Kruisbeek, J. E. Coligan, D. Marguiles, E. Shevach, and W. Strober, eds. Wiley, New York, p. 3.1.1.
34. Faulkner, C. B., J. W. Simecka, M. K. Davidson, J. K. Davis, T. R. Schoeb, J. R. Lindsey, and M. P. Everson. 1995. Gene expression and production of tumor necrosis factor a, interleukin 1, interleukin 6, and γ interferon in C3H/HeN and C57BL/6N mice in acute Mycoplasma pulmonis disease. Infect. Immun. 63:4084.
35. Shakhov, A. N. 1994. New derivative of pMUS for quantitation of mouse IL-12 (p35, p40), IL-10 and IFN-γ-R mRNAs. Eur. Cytokine Network 5:337.
36. Simecka, J. W. 1999. β-Chemokines are produced in lungs of mice with mycoplasma respiratory disease. Curr. Microbiol. 39:163.
37. Overcash, R. G., J. R. Lindsey, G. H. Cassel, and H. J. Baker. 1976. Enhancement of natural and experimental respiratory mycoplasmosis in rats by hexamethylphosphoramide. Am. J. Pathol. 82:171.
38. Pinson, D. M., T. R. Schoeb, J. R. Lindsey, and J. K. Davis. 1986. Evaluation by scoring and computerized morphometry of lesions of early Mycoplasma pulmonis infection and ammonia exposure in F344/N rats. Vet. Pathol. 23:550.
39. Schoeb, T. R., M. K. Davidson, and J. R. Lindsey. 1982. Intracage ammonia promotes growth of Mycoplasma pulmonis in the respiratory tract of rats. Infect. Immun. 38:212.
40. Hodge, L. M., and J. W. Simecka. 2002. Role of upper and lower respiratory tract immunity in resistance to mycoplasma respiratory disease. J. Infect. Dis. 186:290.
41. Hasbold, J., J. S. Hong, M. R. Kehry, and P. D. Hodgkin. 1999. Integrating signals from IFN-γ and IL-4 by B cells: positive and negative effects on CD40 ligand-induced proliferation, survival, and division-linked isotype switching to IgG1, IgE, and IgG2a. J. Immunol. 163:4175.
42. Shinkai, K., M. Mohrs, and R. M. Locksley. 2002. Helper T cells regulate type-2 innate immunity in vivo. Nature 420:825.
43. Tang, C., M. D. Inman, N. van Rooijen, P. Yang, H. Shen, K. Matsumoto, and P. M. O'Byrne. 2001. Th type I-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-γ-dependent mechanism. J. Immunol. 166:1471.
44. Ehlers, S., and E. Richter. 2000. γ Interferon is essential for clearing Mycobacterium genavense infection. Infect. Immun. 68:3720.
45. Jankovic, D., M. C. Kullberg, N. Noben-Trauth, P. Caspar, J. M. Ward, A. W. Cheever, W. E. Paul, and A. Sher. 1999. Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile. J. Immunol. 163:337.
46. Souto, J. T., J. C. Aliberti, A. P. Campanelli, M. C. Livonesi, C. M. Maffei, B. R. Ferreira, L. R. Travassos, R. Martinez, M. A. Rossi, and J. S. Silva. 2003. Chemokine production and leukocyte recruitment to the lungs of Paracoccidioides brasiliensis-infected mice is modulated by interferon-γ. Am. J. Pathol. 163:583.
47. Sugawara, L. H. Yamada, S. Mizuno, and Y. Iwakura. 2000. IL-4 is required for defense against mycobacterial infection. Microbiol. Immunol. 44:971.
48. Volkmann, L., M. Saeftel, O. Bain, K. Fischer, B. Fleischer, and A. Hoerauf. 2001. Interleukin-4 is essential for the control of microfilariae in murine infection with the filaria Litomosoides sigmodontis. Infect. Immun. 69:2950.
49. Seggev, J. S., G. V. Sedmak, and V. P. Kurup. 1996. Isotype-specific antibody responses to acute Mycoplasma pneumoniae infection. Ann. Allergy Asthma Immunol. 77:67.
50. Granstrom, M., T. Holme, A. M. Sjogren, A. Ortqvist, and M. Kalin. 1994. The role of IgA determination by ELISA in the early serodiagnosis of Mycoplasma pneumoniae infection, in relation to IgG and μ-capture IgM methods. J. Med. Microbiol. 40:288.
51. Hickman-Davis, J. M. 2002. Role of innate immunity in respiratory mycoplasma infection. Front. Biosci. 7:d1347.
52. Hickman-Davis, J. M., F. C. Fang, C. Nathan, V. L. Shepherd, D. R. Voelker, and J. R. Wright. 2001. Lung surfactant and reactive oxygen-nitrogen species: antimicrobial activity and host-pathogen interactions. Am. J. Physiol. Lung Cell Mol. Physiol. 281:L517.
53. Hickman-Davis, J. M., S. M. Michalek, J. Gibbs-Erwin, and J. R. Lindsey. 1997. Depletion of alveolar macrophages exacerbates respiratory mycoplasmosis in mycoplasma-resistant C57BL mice but not mycoplasma-susceptible C3H mice. Infect. Immun. 65:2278.
54. Jones, H. P., and J. W. Simecka. 2003. T lymphocyte responses are critical determinants in the pathogenesis and resistance to mycoplasma respiratory disease. Front. Biosci. 8:D930.
55. Mosser, D. M. 2003. The many faces of macrophage activation. J. Leukocyte Biol. 73:209.
56. Lai, W. C., S. P. Pakes, Y. S. Lu, and C. F. Brayton. 1987. Mycoplasma pulmonis infection augments natural killer cell activity in mice. Lab. Anim. Sci. 37:299.
57. Lai, W. C., M. Bennett, S. P. Pakes, V. Kumar, D. Steutermann, I. Owusu, and A. Mikhael. 1990. Resistance to Mycoplasma pulmonis mediated by activated natural killer cells. J. Infect. Dis. 161:1269.
58. Infante-Duarte, C., and T. Kamradt. 1999. Th1/Th2 balance in infection. Springer Semin. Immunopathol. 21:317.
59. Jackson, R. J., A. J. Ramsay, C. D. Christensen, S. Beaton, D. F. Hall, and I. A. Ramshaw. 2001. Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. J. Virol. 75:1205.
60. Sharma, S., and M. Bose. 2001. Role of cytokines in immune response to pulmonary tuberculosis. Asian Pac. J. Allergy Immunol. 19:213.
61. Yang, X. 2001. Distinct function of Th1 and Th2 type delayed type hypersensitivity: protective and pathological reactions to chlamydial infection. Microsc. Res. Tech. 53:273.